2023
DOI: 10.1002/ila2.5
|View full text |Cite
|
Sign up to set email alerts
|

iLABMED, why now and how in the future?

Abstract: Nowadays, public health is facing many challenges, mainly including non‐communicable diseases and communicable diseases. Communicable diseases, particularly emerging infectious diseases, have also attracted attention due to their enormous impact on public health and the global economy. The most prominent example is the current global Coronavirus Disease 2019 (COVID‐19) pandemic. The unprecedented and ongoing COVID‐19 pandemic has highlighted the necessity for readily available, accurate, and rapid laboratory m… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 16 publications
0
1
0
Order By: Relevance
“…iLABMED , as an emerging journal majored in laboratory medicine, will closely catch up these trends, seize the opportunities, and cope with the challenges in 2024 and beyond (Figure 1). We will follow the adopts of the “four I” strategy, namely “Innovation”, “Intelligence”, “Integration”, and “International” [33], strengthen our platform, and certainly, create a bright future. Again, any contributions for iLABMED including (but not limiting in) joining us as international editorial members, submitting high‐quality manuscripts, helping us as reviewers, and providing other constructive suggestions are highly anticipated and appreciated.…”
Section: Figurementioning
confidence: 99%
“…iLABMED , as an emerging journal majored in laboratory medicine, will closely catch up these trends, seize the opportunities, and cope with the challenges in 2024 and beyond (Figure 1). We will follow the adopts of the “four I” strategy, namely “Innovation”, “Intelligence”, “Integration”, and “International” [33], strengthen our platform, and certainly, create a bright future. Again, any contributions for iLABMED including (but not limiting in) joining us as international editorial members, submitting high‐quality manuscripts, helping us as reviewers, and providing other constructive suggestions are highly anticipated and appreciated.…”
Section: Figurementioning
confidence: 99%